Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to assess the safety, pharmacokinetics and efficacy of KRN23 in adult Chinese patients with TIO


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05357573
Study type Interventional
Source Kyowa Kirin Co., Ltd.
Contact
Status Active, not recruiting
Phase Phase 4
Start date September 7, 2022
Completion date December 2023

See also
  Status Clinical Trial Phase
Active, not recruiting NCT04783428 - Tumor-induced Osteomalacia Disease Monitoring Program